Clinical feature | All(N = 60) |
---|---|
Age | 58(32–76) |
Gender | Â |
57(95%) | 3 (5%) |
ECOG | Â |
0 | 42(70%) |
1 | 18(30%) |
HBV | Â |
Yes | 45(75%) |
No | 15(25%) |
AFP | Â |
≥ 400 | 18(30%) |
< 400 | 42(70%) |
Differentiation | Â |
Moderate | 18(30%) |
Moderate-poor | 18(30%) |
Poor | 24(40%) |
Effect | Â |
CR | 1 (2%) |
PR | 18(30%) |
SD | 30(50%) |
PD | 11(18%) |
GPC3 expression | Â |
Negative | 12(20%) |
Weakly positive | 18(30%) |
Moderate positive | 13(22%) |
Strongly positive | 17(28%) |